Osteonecrosis: Etiology, diagnosis, and treatment

Current Opinion in Rheumatology

Volumn 16, Issue 4, 2004, Pages 443-449

  Jones, Lynne C ^a,b   Hungerford, David S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Avascular necrosis; Diseases of the hip; Osteonecrosis

Indexed keywords

ALCOHOL; CORTICOSTEROID; DEXAMETHASONE; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; MEVINOLIN;

ARTHROPLASTY; BONE NECROSIS; BONE TRANSPLANTATION; CEMENTATION; COLLAPSE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; GENETIC PREDISPOSITION; HIP ARTHROPLASTY; HUMAN; JOINT; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOTOMY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

HUMANS; OSTEONECROSIS;

EID: 3042580702     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000127829.34643.fd     Document Type: Review

References (47)

1. Ito H, Matsuno T, Omizu N, et al.: Mid-term prognosis of non-traumatic osteonecrosis of the femoral head. J Bone Joint Surg Br 2003, 85:796-801. The results of this paper demonstrate the variable nature of this disease.
2. Kim Y-M, Rhyu KH, Lee SH, et al.: Can osteonecrosis of the femoral head be recurrent? Clin Res Rel Res 2003, 406:123-128. Although repeated episodes of osteonecrosis may occur, this is a relatively rare event.
3. Hernigou P, Bachir D, Galacteros F: The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am 2003, 85:500-504. This presents an analysis of the radiographic and clinical progression of osteonecrosis in patients with sickle cell disease.
4. Glueck CJ, Freiberg RA, Wang P: Role of thrombosis in osteonecrosis. Curr Hematol Rep 2003, 2:417-422. This is a review of the literature and current opinion of one of the leaders in the field supporting that venous thrombosis causes osteonecrosis.
5. Jones JPJ: Intravascular coagulation and osteonecrosis. Clin Orthop 1992, 277:41-53.
6. Jones LC, Mont MA, Le TB, et al.: Procoagulants and osteonecrosis. J Rheumatol 2003, 30:783-791. This study reports that most patients with osteonecrosis may have abnormal levels of a coagulation factor.
7. Lee J-S, Koo K-H, Ha Y-C, et al.: Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Res Rel Res 2003, 417:270-276. The investigators did not find any differences in coagulation factor levels or abnormalities between osteonecrosis patients and matched controls in an East Asian population.
8. Gasiorowski J, Knysz B, Sokolska V, et al.: Avascular necrosis of femoral heads in a man with HIV infection. Lancet Infect Dis 2003, 3:708.
9. Allison G, Bostrom M, Glesby M: Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS 2003, 17:1-9.
10. Glesby MJ: Bone disorders in human immunodeficiency virus infection. Clin Infect Dis 2003, 37(suppl 2):s91-s95. This is a concise, well-written review of bone disorders, including osteonecrosis, in patients with HIV infection.
11. Valencia M, Barreiro P, Soriano V, et al.: Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: study of seven cases. HIV Clin Trials 2003, 4:132-136. This report supports the growing evidence of an association between osteonecrosis and HIV infection.
12. Wang Y, Li Y, Mao K, et al.: Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop 2003, 410:213-224. This is another publication from an outstanding research group studying the pathogenic mechanisms that may be involved in alcohol-associated osteonecrosis. There study included both in vivo and in vitro support for the concept that precursor cells may be directed towards adipogenesis and away from osteogenesis in patients with alcohol-associated osteonecrosis.
13. Chao Y-C, Wang S-J, Chu H-C, et al.: Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcoholism 2003, 38:431-436. The investigators conclude that alcoholic patients who develop osteonecrosis are less likely to carry the ADH2*1 allele (on gene coding for alcohol-metabolizing enzyme).
14. Asano T, Takahashi KA, Fujioka M, et al.: ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 2003, 13:675-682. This study demonstrated that the ABCB1 3435TT genotype for a drug-transport protein had a significantly lower incidence in patients receiving steroid therapy who eventually developed osteonecrosis. This may eventually lead to being able to screen patients scheduled to undergo steroid therapy to determine who is at risk.
15. Stevens K, Tao C, Lee S-U, et al.: Subchondral fractures in osteonecrosis of the femoral head: comparison of radiography, CT, and MR imaging. AJR Am J Roentgenol 2003, 180:363-368. More subchondral fractures were detected by CT scanning (using a helical scanner) than by MRI.
16. Cherian SF, Laorr A, Saleh KJ, et al.: Quantifying the extent of femoral head involvement in osteonecrosis. J Bone Joint Surg Am 2003, 85:309-315. This study evaluated three commonly used methods to quantify the extent of the necrotic lesion. All three methods were able to predict which lesions were at risk for subchondral collapse.
17. Koo K-H, Kim R: Quantifying the extent of osteonecrosis of the femoral head: a new method using MRI. J Bone Joint Surg Br 1995, 77:875-880.
18. Kishida Y, Nishii T, Sugano N, et al.: Measurement of lesion area and volume by three-dimensional spoiled gradient-echo MR imaging in osteonecrosis of the femoral head. J Orthop Res 2003, 21:850-858. Three-dimensional spoiled gradient-echo MRI can be used to accurately measure lesion area and, perhaps, volume. It has the added advantage of requiring less imaging time.
19. Tsuji T, Sugano N, Sakai T, et al.: Evaluation of femoral perfusion in a non-traumatic rabbit osteonecrosis model with T2*-weighted dynamic MRI. J Orthop Res 2003, 21:341-351. This study describes T2-weighted dynamic MRI, which can be used to determine regional tissue perfusion. The use of this diagnostic tool may eventually lead to a diagnosis of osteonecrosis in earlier stages of the disease.
20. Hernigou P, Bachir D, Galacteros F: Avascular necrosis of the femoral head in sickle-cell disease: treatment of collapse by the injection of acrylic cement. J Bone Joint Surg Br 1993, 75:875-880.
21. Wood ML, McDowell CM, Kelley SS: Cementation for femoral head osteonecrosis: a preliminary clinic study. Clin Orthop 2003, 412:94-102.
22. Rijnen WHC, Gardeniers JWM, Buma P, et al.: Treatment of femoral head osteonecrosis using bone impaction grafting. Clin Orthop 2003, 417:74-83.
23. Mont MA, Etienne G, Ragland PS: Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop 2003, 417:84-92. The investigators report on their experience with a BMP-enriched allograft used to fill the defect created with the trap-door grafting procedure.
24. Berend KR, Gunneson EE, Urbaniak JR: Free vascularized fibular grafting for the treatment of postcollapse osteonecrosis of the femoral head. J Bone Joint Surg Am 2003, 85:987-993. This is one of the most recent publications from the group at Duke University that has an extensive experience with free vascularized fibular grafting for the treatment of osteonecrosis. This study indicates that this treatment can be successfully used in patients with postcollapse necrotic lesions.
25. Plakseychuk AY, Kim S-Y, Park B-C, et al.: Vascularized compared with non-vascularized fibular grafting for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am 2003, 85:589-596. Vascularization improves the clinical outcome of fibular grafting in osteonecrosis patients.
26. Dailiana ZH, Gunneson EE, Urbaniak JR: Heterotopic ossification after treatment of femoral head osteonecrosis with free vacularized fibular graft. J Arthroplasty 2003, 18:83-88.
27. Beaule PE, LeDuff M, Amstutz HC: Hemiresurfacing arthroplasty of the hip for failed free-vascularized fibular graft. J Arthroplasty 2003, 18:519-523.
28. Berend KR, Gunneson EE, Urbaniak JR, et al.: Hip arthroplasty after failed free vascularized fibular grafting for osteonecrosis in young patients. J Arthroplasty 2003, 18:411-419.
29. Hasegawa Y, Sakano S, Iwase T, et al.: Pedicle bone grafting versus transtrochanteric rotational osteotomy for avascular necrosis of the femoral head. J Bone Joint Surg Br 2003, 85:191-198. Although the survival rates were somewhat similar for the two groups, there were a significant number of major postoperative complications with the osteotomy procedure compared with none for the pedicle bone grafting group.
30. Fuchs B, Knothe U, Hertel R, et al.: Femoral osteotomy and iliac graft vascularization for femoral head osteonecrosis. Clin Orthop 2003, 412:84-93.
31. Drescher W, Furst M, Hahne HJ, et al.: Survival analysis of hips treated with flexion osteotomy for femoral head necrosis. J Bone Joint Surg Br 2003, 85:969-974. This study reports a survival rate of 90% at 5 years. The survival rate was highest for ficat stage II hips.
32. Hisatome T, Yasunaga Y, Takahashi K, et al.: Progressive collapse of transposed necrotic area after transtrochanteric rotational osteotomy for osteonecrosis of the femoral head induces osteoarthritic change: mid-term result of transtrochanteric rotational osteotomy for osteonecrosis of the femoral head. Arch Orthop Trauma Surg 2003, 5:1-10. Eighty percent of the surgeries had good or excellent clinical results at follow-up. There is concern with a high rate of collapse of the transposed area.
33. Adili A, Trousdale R: Femoral head resurfacing for the treatment of osteonecrosis in the young patient. Clin Orthop 2003, 417:93-101. The authors indicate that the outcome for this procedure is unpredictable and offer it as an interim procedure.
34. Mont MA, Hungerford DS: Non-traumatic avascular necrosis of the femoral head. J Joint Bone Joint Surg Am 1995, 77:459-474.
35. Ortiguera C, Pulliam I, Cabanela M: Total hip arthroplasty for osteonecrosis: matched pair analysis of 188 hips with long-term follow-up. J Arthroplasty 1999, 14:21-28.
36. Cornell C, Salvati E, Pellicci P: Long-term follow-up of total hip replacement in patients with osteonecrosis. Orthop Clin North Am 1985, 16:757-769.
37. Garino J, Steinberg M: Total hip arthroplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year followup. Clin Orthop 1997, 334:108-115.
38. Xenakis T, Gelalis J, Koukoubis T, et al.: Cementless hip arthroplasty in the treatment of patients with femoral head necrosis. Clin Orthop 2001, 386:93-99.
39. Kim Y-H, Oh SH, Kim JS, et al.: Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral head. J Bone Joint Surg Am 2003, 85:675-681. This study provides evidence that new-generation THR yields better results for osteonecrosis patients than reported in past clinical series.
40. Nich C, Ali E-HS, Hannouche D, et al.: Long-term results of alumina-on-alumina hip arthroplasty for osteonecrosis. Clin Orthop 2003, 417:102-111. It may be possible to address concerns with the activity demands of the younger osteonecrosis patient on the longevity of a THR by the use of ceramic-on-ceramio prostheses.
41. Reis ND, Schwartz O, Militianu D, et al.: Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surg Br 2003, 85:371-375. The results for the treatment of osteonecrosis with HBO are remarkable. However, the therapy needs to become more accessible and less costly in terms of time and money.
42. Cui Q, Wang GJ, Su CC, et al.: The Otto Aufranc award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop 1997, 344:8-19.
43. Wang G-J, Cui Q, Balian G: The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop 2000, 370:295-310.
44. Li X, Cui Q, Kao C, et al.: Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARY2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003, 33:652-659. This article provides basic science support for the use of lovastatin to treat alcohol-associated osteonecrosis.
45. Lee H-S, Huang G-T, Chiang H, et al.: Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 2003, 21:190-199. This study indicates that multipotential MSCs removed from the bone marrow near osteonecrosis lesions can be isolated and culture expanded. This may eventually provide a source of cells for cell-based therapies.
46. Mont M, Jones L, Einhorn T, et al.: Osteonecrosis of the femoral head: potential with growth and differentiation factors. Clin Orthop 1998, 355S: S314-S335.
47. Yang C, Yang S, Du J, et al.: Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit. Chin Med J (Engl) 2003, 116:1544-1548. The investigators describe the application of gene transfection for the treatment of osteonecrosis. Using a plasmid containing a gene for VEGF, they showed that angiogenesis and osteogenesis could be stimulated in an animal model of osteonecrosis.